Intermittent electrical stimulation of the right cervical vagus nerve in salt-sensitive hypertensive rats: effects on blood pressure, arrhythmias, and ventricular electrophysiology

Hypertension (HTN) is the single greatest risk factor for potentially fatal cardiovascular diseases. One cause of HTN is inappropriately increased sympathetic nervous system activity, suggesting that restoring the autonomic nervous balance may be an effective means of HTN treatment. Here, we studied the potential of vagus nerve stimulation (VNS) to treat chronic HTN and cardiac arrhythmias through stimulation of the right cervical vagus nerve in hypertensive rats. Dahl salt‐sensitive rats (n = 12) were given a high salt diet to induce HTN. After 6 weeks, rats were randomized into two groups: HTN‐Sham and HTN‐VNS, in which VNS was provided to HTN‐VNS group for 4 weeks. In vivo blood pressure and electrocardiogram activities were monitored continuously by an implantable telemetry system. After 10 weeks, rats were euthanized and their hearts were extracted for ex vivo electrophysiological studies using high‐resolution optical mapping. Six weeks of high salt diet significantly increased both mean arterial pressure (MAP) and pulse pressure, demonstrating successful induction of HTN in all rats. After 4 weeks of VNS treatment, the increase in MAP and the number of arrhythmia episodes in HTN‐VNS rats was significantly attenuated when compared to those observed in HTN‐Sham rats. VNS treatment also induced changes in electrophysiological properties of the heart, such as reduction in action potential duration (APD) during rapid drive pacing, slope of APD restitution, spatial dispersion of APD, and increase in conduction velocity of impulse propagation. Overall, these results provide further evidence for the therapeutic efficacy of VNS in HTN and HTN‐related heart diseases.

[1]  Bruce D. Johnson,et al.  Diastolic dysfunction: a link between hypertension and heart failure. , 2008, Drugs of today.

[2]  Philippe Van De Borne,et al.  Guidelines for the management of arterial hypertension , 2014 .

[3]  A. Oto,et al.  Hypertension and arrhythmia: blood pressure control and beyond. , 2002, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[5]  M. Epstein Resistant Hypertension: Prevalence and Evolving Concepts , 2007, Journal of clinical hypertension.

[6]  M. Esler,et al.  Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. , 2003, Acta physiologica Scandinavica.

[7]  D L Kunze,et al.  Reflex discharge patterns of cardiac vagal efferent fibres , 1972, The Journal of physiology.

[8]  A. Garfinkel,et al.  Mechanisms of Discordant Alternans and Induction of Reentry in Simulated Cardiac Tissue , 2000, Circulation.

[9]  R. Gray,et al.  Spatial and temporal organization during cardiac fibrillation , 1998, Nature.

[10]  S. S. Hull,et al.  Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. , 1991, Circulation research.

[11]  A. Schuchat DEPARTMENT OF HEALTH & HUMAN SERVICES , 2015 .

[12]  S. Julius,et al.  Consequences of the increased autonomic nervous drive in hypertension, heart failure and diabetes. , 1998, Blood pressure. Supplement.

[13]  Brian Olshansky,et al.  Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. , 2008, Circulation.

[14]  M. Yacoub,et al.  Altered connexin expression in human congestive heart failure. , 2001, Journal of molecular and cellular cardiology.

[15]  T. Ishikawa,et al.  Involvement of the autonomic nervous system in diurnal variation of corrected QT intervals in common marmosets. , 2013, Journal of pharmacological sciences.

[16]  P. A. Zwieten Pharmacological Profile of Barnidipine: A Single Optical Isomer Dihydropyridine Calcium Antagonist , 1998 .

[17]  Fernando L. Vale,et al.  Vagus Nerve Stimulation for Treatment of Epilepsy , 2016 .

[18]  J. Merino,et al.  Evidence favoring the hypothesis that ventricular arrhythmias have prognostic significance in left ventricular hypertrophy secondary to systemic hypertension. , 1995, The American journal of cardiology.

[19]  T. J. Reeves,et al.  Effects of efferent vagal stimulation on atrial and ventricular function. , 1968, The American journal of physiology.

[20]  P. Guyenet The sympathetic control of blood pressure , 2006, Nature Reviews Neuroscience.

[21]  R. Prescott,et al.  Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.

[22]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[23]  Zoran B. Popović,et al.  Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model , 2009, Circulation. Heart failure.

[24]  David J. Christini,et al.  Effect of β-adrenergic blockade on dynamic electrical restitution in vivo , 2004 .

[25]  Imad Libbus,et al.  Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. , 2014, Journal of cardiac failure.

[26]  J. Armour The little brain on the heart. , 2007, Cleveland Clinic journal of medicine.

[27]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[28]  A. Sved,et al.  Brainstem mechanisms of hypertension: Role of the rostral ventrolateral medulla , 2003, Current hypertension reports.

[29]  J. Coote,et al.  Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation. , 2011, Cardiovascular research.

[30]  Ettore Ambrosioni,et al.  ESH/ESC guidelines for the management of arterial hypertension: how to implement in daily clinical practice , 2004 .

[31]  Jeroen J. Bax,et al.  Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[32]  W H Lamers,et al.  Spatial distribution of connexin43, the major cardiac gap junction protein, in the developing and adult rat heart. , 1991, Circulation research.

[33]  Suneet Mittal,et al.  Effect of beta-adrenergic blockade on dynamic electrical restitution in vivo. , 2004, American journal of physiology. Heart and circulatory physiology.

[34]  D. Woodbury,et al.  Effects of Vagal Stimulation on Experimentally Induced Seizures in Rats , 1990, Epilepsia.

[35]  Guilbert Jj The world health report 2002 - reducing risks, promoting healthy life. , 2003 .

[36]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[37]  G. Bakris,et al.  Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. , 2012, Journal of the American Society of Hypertension : JASH.

[38]  J. Coote,et al.  Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart , 2007, The Journal of physiology.

[39]  K. Tracey Physiology and immunology of the cholinergic antiinflammatory pathway. , 2007, The Journal of clinical investigation.

[40]  K. Muramoto,et al.  Efferent Vagal Nerve Stimulation Protects Heart Against Ischemia-Induced Arrhythmias by Preserving Connexin43 Protein , 2005, Circulation.

[41]  Per Capita,et al.  About the authors , 1995, Machine Vision and Applications.

[42]  S. Priori,et al.  Protective Effect of Vagal Stimulation on Reperfusion Arrhythmias in Cats , 1987, Circulation research.

[43]  R. Iliescu,et al.  Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex. , 2010, American journal of physiology. Heart and circulatory physiology.

[44]  F. Cuccurullo,et al.  Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. , 2005, American journal of hypertension.

[45]  V. Hombach,et al.  The arrhythmogenic substrate of the long QT syndrome: genetic basis, pathology, and pathophysiologic mechanisms. , 1993, European heart journal.

[46]  B. O’Rourke,et al.  Cardiac mitochondria and arrhythmias. , 2010, Cardiovascular research.

[47]  M. Raizada,et al.  Circulating angiotensin II and dietary salt: Converging signals for neurogenic hypertension , 2007, Current hypertension reports.

[48]  Helmut Baumgartner,et al.  The 2013 ESH/ESC guidelines for the management of arterial hypertension , 2013 .

[49]  J. Osborn,et al.  The effect of cardiac sympathetic denervation through bilateral stellate ganglionectomy on electrical properties of the heart. , 2011, American journal of physiology. Heart and circulatory physiology.

[50]  E. McLachlan,et al.  Dependence of deoxycorticosterone/salt hypertension in the rat on the activity of adrenergic cardiac nerves. , 1979, Clinical science.

[51]  N. Chattipakorn,et al.  Vagus nerve stimulation initiated late during ischemia, but not reperfusion, exerts cardioprotection via amelioration of cardiac mitochondrial dysfunction. , 2014, Heart rhythm.

[52]  H. L. Stone,et al.  Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. , 1984, Circulation.

[53]  J. Osborn,et al.  Role of spinal V1a receptors in regulation of arterial pressure during acute and chronic osmotic stress. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[54]  D. Cysarz,et al.  Heart rate variability: how to assess effects of mild therapies on autonomic control in small groups of mild and borderline hypertensives? , 2000, Hypertension.

[55]  H. Sabbah Baroreflex Activation for the Treatment of Heart Failure , 2012, Current Cardiology Reports.

[56]  Jens Jordan,et al.  Carotid Baroreceptor Stimulation, Sympathetic Activity, Baroreflex Function, and Blood Pressure in Hypertensive Patients , 2010, Hypertension.

[57]  M. Esler,et al.  Measurement of Sympathetic Nervous System Activity in Heart Failure: The Role of Norepinephrine Kinetics , 2000, Heart Failure Reviews.

[58]  J. Coote,et al.  Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation , 2009, The Journal of physiology.

[59]  J. O. Foley,et al.  Quantitative studies of the vagus nerve in the cat. I. The ratio of sensory to motor fibers , 1937 .

[60]  J. Guilbert The world health report 2002 - reducing risks, promoting healthy life. , 2003, Education for health.

[61]  A. Kemeny,et al.  Slow Hyperpolarization in Cortical Neurons: A Possible Mechanism Behind Vagus Nerve Simulation Therapy for Refractory Epilepsy? , 2000, Epilepsia.

[62]  Elena G. Tolkacheva,et al.  Intermittent vagal nerve stimulation alters the electrophysiological properties of atrium in the myocardial infarction rat model , 2014, 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[63]  Markus Zabel,et al.  Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. , 2011, European heart journal.

[64]  P. Weidmann,et al.  Normotensive offspring of hypertensive parents: no evidence of left ventricular diastolic dysfunction in a cross-sectional study. , 1998, Blood pressure.

[65]  Richard A Gray,et al.  Effect of Action Potential Duration and Conduction Velocity Restitution and Their Spatial Dispersion on Alternans and the Stability of Arrhythmias , 2002, Journal of cardiovascular electrophysiology.

[66]  P. Sorlie,et al.  The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide , 2004, Hypertension.